Follow
Won Young Lim
Won Young Lim
Organic Chemistry, Medicinal Chemistry
No verified email
Title
Cited by
Cited by
Year
Synthesis and evaluation of sulfonyl piperazine LpxH inhibitors
SH Kwak, CS Cochrane, AF Ennis, WY Lim, CG Webster, J Cho, ...
Bioorganic chemistry 102, 104055, 2020
152020
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus
MJ Hoy, E Park, H Lee, WY Lim, DC Cole, ND DeBouver, BG Bobay, ...
MBio 13 (3), e01049-22, 2022
102022
SARS-CoV-2 hijacks host cell genome instability pathways
J Victor, T Jordan, E Lamkin, K Ikeh, A March, J Frere, A Crompton, ...
Research square, 2022
62022
REV1 inhibition enhances radioresistance and autophagy
KE Ikeh, EN Lamkin, A Crompton, J Deutsch, KJ Fisher, M Gray, DJ Argyle, ...
Cancers 13 (21), 5290, 2021
62021
Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY
SH Kwak, WY Lim, A Hao, EH Mashalidis, DY Kwon, P Jeong, MJ Kim, ...
European journal of medicinal chemistry 215, 113272, 2021
42021
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22-modified FK520 analog against C. neoformans
JH Angela Rivera, Won Young Lim, Eunchong Park, Patrick A. Dome, Michael J ...
mBio, 2023
12023
SARS-CoV-2 hijacks host cell genome instability pathways (preprint)
N CHATTERJEE, J Victor, T Jordan, E Lamkin, K Ikeh, A March, J Frere, ...
2022
REV1 Inhibition Enhances Radioresistance and Autophagy. Cancers 2021, 13, 5290
KE Ikeh, EN Lamkin, A Crompton, J Deutsch, KJ Fisher, M Gray, DJ Argyle, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–8